Vor Biopharma Stock (NASDAQ: VOR) stock price, news, charts, stock research, profile.
Open | $1.760 |
Close | - |
Volume / Avg. | 29.536K / 346.177K |
Day Range | 1.750 - 1.810 |
52 Wk Range | 1.620 - 5.700 |
Market Cap | $118.695M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 9.14% |
Days to Cover | 10.56 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vor Biopharma (NASDAQ: VOR) through any online brokerage.
Other companies in Vor Biopharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and FibroGen (NASDAQ:FGEN).
The latest price target for Vor Biopharma (NASDAQ: VOR) was reported by Wedbush on Friday, May 10, 2024. The analyst firm set a price target for 11.00 expecting VOR to rise to within 12 months (a possible 532.18% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Vor Biopharma (NASDAQ: VOR) is $1.74 last updated Today at May 10, 2024 at 10:01 AM EDT.
There are no upcoming dividends for Vor Biopharma.
Vor Biopharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Vor Biopharma.
Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.